|
- Genomics - Global - World Health Organization (WHO)
Genomics is evolving rapidly, and its potential impact for the future of human health cannot yet be known Human genomics knowledge and technologies provide new ways to prevent and manage many diseases, and opportunities to achieve global public health goals Genomic knowledge of other organisms contributes to the understanding of human health and diseases, the interconnectedness across
- Global genomic surveillance strategy for pathogens with pandemic and . . .
Global genomic surveillance strategy for pathogens with pandemic and epidemic potential, 2022–2032 The Strategy provides a high-level unifying framework to leverage existing capacities, address barriers and strengthen the use of genomic surveillance in the detection, monitoring and response to public health threats Genomic surveillance is part of the broader surveillance and laboratory
- News - World Health Organization (WHO)
Abortion: Safety Accessing and implementing GCF readiness funds Addictive behaviours: Gaming disorder Adolescent health and development Adolescent sexual and reproductive health Ageing: Ageism Ageing: Global population Air pollution: Personal interventions and risk communication Air pollution: Reducing short-lived climate pollutants Antibiotic resistance: Why vaccination is important
- WHO releases new principles for ethical human genomic data collection . . .
The World Health Organization (WHO) has issued a set of principles for the ethical collection, access, use and sharing of human genomic data Created with guidance from the WHO Technical Advisory Group on Genomics (TAG-G) and other international experts, these principles establish a global approach to help protect individual rights, promote equity and foster responsible collaboration in
- COVID-19 - Global Situation
To permit robust COVID-19 risk assessment and management, WHO reiterates its recommendations to Member States to continue to monitor and report SARS-CoV-2 activity and burden, public health and healthcare system impacts of COVID-19, strengthen genomic sequencing capacity and reporting, in particular information on SARS-CoV-2 variants [6
- Global genomic surveillance strategy for pathogens with pandemic and . . .
Genomic surveillance is part of the broader surveillance and laboratory system, and its implementation should reinforce end-to-end capacities including sample collection, diagnostics, data sharing and analysis The strategy aims to facilitate the connectivity between different disease control programs and surveillance networks
- Genomics costing tool - World Health Organization (WHO)
The first edition of the genomics costing tool (GCT) facilitates budgeting and resource mobilization for infrastructure, workforce, biosafety and quality assurance associated with SARS-CoV-2 genomic surveillance This tool will be useful to country, regional and global policymakers, health administrators and economists, laboratory directors, quality managers, donor institutions and other
- The essential task of strengthening genomic surveillance: WHO in . . .
The crucial role of effective genomic surveillanceWith the COVID-19 pandemic progressing, genomic surveillance, conducted in an efficient way, is essential to inform us of circulating viruses and response measures required The sequencing of representative samples continuously collected in a standardized approach from patients meeting influenza-like illness, acute respiratory infection, and
|
|
|